MedTrace Logo

Mesenchymal Stem Cells in Knee Cartilage Injuries

NCT02118519 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2016-02-24

No results posted yet for this study

Summary

Induction of autologous repair chondrogenesis to regenerate injured articular cartilage using bone marrow mesenchymal stem cells (MSCs) after in vitro expansion under restricted culturing conditions.

Conditions

  • Articular Cartilage Disorder of Knee
  • Osteoarthritis, Knee

Interventions

BIOLOGICAL

Autologous Mesenchymal Stem Cells

Comparison of clinical outcomes of patients injected by mesenchymal stem cells only with patients injected with mesenchymal stem cells supported by platelet lysate

Sponsors & Collaborators

  • University of Jordan

    lead OTHER

Principal Investigators

  • Abdallah Awidi, MD · Cell Therapy Center

  • Mahasen S Najjar, MD · Jordan University Hospital

  • Hiba Khalil, PhD · Al-Neelain University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
68 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • Jordan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02118519 on ClinicalTrials.gov